In this manuscript, the authors describe their findings of an extensive literature review of 12 mostly observational, retrospective studies evaluating the use of dual antiplatelet therapy (DAPT) in patients after CABG. They conclude that there is no clear consensus regarding the use DAPT in patients undergoing CABG. Nevertheless, if not contraindicated, it is reasonable to use DAPT following CABG in the setting of acute coronary syndrome, starting in the postoperative period when chest tube drainage is acceptable.
You are here:
Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome
Submitted by: J. Rafael Sadaba
Source: American Journal of Cardiology
Keywords:
Author(s): Bomb R, Oliphant CS, Khouzam RN.
1 Comment
I think there is a place for dual anti platelet therapy after CABG when there are stented vessels and in case bad coronary disease(diffuse calcifications and small vessels.
we are waiting for the randomized trials to give the scientific answer